Matthew Patterson

Matthew Patterson is an accomplished executive in the biotechnology sector with extensive experience in leadership roles. Currently serving as a Venture Partner at SR One Capital Management and Executive Chairman at Addition Therapeutics, Patterson also holds positions as Chairman of the Board and Executive Chairman at Remix Therapeutics. Notable past roles include Member and Chairman of the Board at Vor Biopharma, as well as Chairman and Chief Executive Officer of Iris Medicine. Patterson's track record extends to multiple companies including Audentes Therapeutics, where Matthew held several key leadership roles, and a board membership at Homology Medicines, Inc. Additionally, Patterson contributed to the Alliance for Regenerative Medicine as Chairman and Vice Chairman. An alumnus of Bowdoin College with a BA in Biochemistry, Patterson has dedicated efforts to organizations such as Gilda’s Club New York City, focusing on providing support for individuals affected by cancer.